BL
BLFE.US BioLife Sciences Inc
- Market cap
- USD 318K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Aug 2023.
Is BLFE.US undervalued?
Graham numberThe Graham number of BioLife Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BioLife Sciences Inc fundamental analysis
No fundamental analysis for BioLife Sciences Inc yet.
BioLife Sciences Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BioLife Sciences Inc
BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.
Full company profileBioLife Sciences Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Aug 31, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
BioLife Sciences Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | - | - | - | - | 412K | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | -985K | - | - | - |
| Operating Income | -7.31K | -10.7K | -21.2K | -12.5K | -329K | -42.3K | - | -1.24M | - | - | - |
| EBITDA | -7.31K | -10.7K | -21.2K | -12.5K | -329K | -42.3K | 172K | -1.22M | - | - | - |
| Net Income | -31.2K | -10.7K | -28.9K | -19.2K | -340K | -52.7K | -1.13K | -1.27M | - | - | - |
| EPS | -0.03 | -0.01 | -0.07 | -0.05 | -0.08 | 0.00 | 0.00 | -0.02 | - | - | - |
| Balance Sheet | |||||||||||
| Total Assets | - | - | - | - | 12.3K | 1.32K | 17.00 | 72.7K | - | - | 1.04K |
| Total Liabilities | - | - | 127K | 146K | 195K | 222K | 1.17K | 762K | - | - | 1.15K |
| Shareholders' Equity | - | - | -127K | -146K | -183K | -221K | -1.15K | -690K | - | - | -109.57 |
| Cash & Short-term Investments | - | - | - | - | 12.3K | 1.32K | 17.00 | 34.7K | - | - | 15.62 |
| Total Debt | - | - | 102K | 113K | 141K | 142K | - | 190K | - | - | 398.00 |
| Cash Flow | |||||||||||
| Operating Cash Flow | - | - | - | -11.5K | -18.6K | -12.5K | 17.00 | -884K | -107K | - | -7.84 |
| Capital Expenditure | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 961.00 | 0.00 | - | 0.00 |
| Free Cash Flow | - | - | - | -11.5K | -18.6K | -12.5K | 17.00 | -885K | - | - | -7.84 |
| Ratios | |||||||||||
| ROA | - | - | - | - | -2,755.9% | -3,993.6% | -6,670.6% | -1,743.7% | - | - | - |
| Net Profit Margin | - | - | - | - | - | - | - | -308.0% | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BioLife Sciences Inc dividends
BioLife Sciences Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:75 on Jul 23, 2018.
Who owns BioLife Sciences Inc
Ownership data of BioLife Sciences Inc is not available yet.
BioLife Sciences Inc company profile
- Company name
- BioLife Sciences Inc
- Ticker
- BLFE.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- November
- Address
- 2831 Saint Rose Parkway, Henderson, NV, United States, 89052
- Phone
- 833-919-1037
- Website
- biolifesciences.com
About BioLife Sciences Inc
BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.
BioLife Sciences Inc management
2- Mr. Justin De FourFounder, CEO & Chairman · born 1991
- Ms. Nika JaksicCOO & Director · born 1981